<DOC>
	<DOCNO>NCT02840708</DOCNO>
	<brief_summary>Objective : Evaluate Pharmacokinetics determine safety GM-CSF single dose inhalation . Study Design : Pharmacokinetic open study</brief_summary>
	<brief_title>SK-1401 ( rhGM-CSF Agent Inhalation ) GM-CSF Inhalation Pharmacokinetic Study</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Pulmonary Alveolar Proteinosis</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<criteria>1 . Subjects judge appropriate study attend physician 2. provide sign informed consent . aPAP patient must meet follow 3. aPAP patient age 20 80 year old ( date registration ) 4. aPAP severity mild moderate . ( severe ) Healthy volunteer must meet follow 5 . Japanese healthy male subject age 20 45 year old ( date registration ) . 6 . BMI ( Body mass index ) 18 25 . 1 . WBC 12,000/mcl 2 . Fever 38 degree celsius 3 . History malignant disease within recent 5 year ( apply treat case local basal cell carcinoma ) 4 . Complication severe cardiovascular disease include congestive heart failure , angina pectoris , hemorrhagic tendency , etc . 5 . Complication respiratory disease pulmonary infectious disease ( incl . pulmonary tuberculosis ) , interstitial pneumonitis , lung fibrosis bronchiectasis , evaluation safety GMCSF therapy consider difficult . 6 . History complication infectious disease require systemic administration antibiotic , antifungal antiviral agent within recent 2 week . 7. liver dysfunction 8. renal dysfunction 9 . Previous experience severe unexplained adverse event aerosol delivery kind medicinal product 10 . Positive HIVAb , HBsAg , HCVAb , STS TPHA 11. allergic GMCSF . 12. addicted illegal drug 13 . Participation clinical trial within 12 week registration . 14. smoking within 5 year 15. follow procedure define protocol aPAP patient must exclude follow 16 . Pregnant possibly pregnant woman , lactate woman , woman desire become pregnant study period 17 . Patients treat wholelung lavage , repeat segmentallung lavage , GMCSF rituximab within 6 month start study . 18. take inhalation . Healthy volunteer must exclude follow 19. take medicine ( incl . OTC ) .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>